Daratumumab, cyclophosphamide, bortezomib, and dexamethasone for multiple myeloma: final results of the LYRA study. - Yimer H; Melear J; Faber E; Bensinger WI; Burke JM; Narang M; Stevens D; Gray KS; Lutska Y; Bobba P; Qi K; Hoehn D; et al. (Leukemia & lymphoma, 2022)